Col2CreERT2, a mouse model for a chondrocyte-specific and inducible gene deletion
Author(s) -
Michael Chen,
Siwei Li,
Wanqing Xie,
B Wang,
D Chen
Publication year - 2014
Publication title -
european cells and materials
Language(s) - English
Resource type - Journals
ISSN - 1473-2262
DOI - 10.22203/ecm.v028a16
Subject(s) - chondrocyte , cartilage , osteoarthritis , intervertebral disc , gene , fusion gene , animal model , biology , temporomandibular joint , pathology , degeneration (medical) , microbiology and biotechnology , medicine , bioinformatics , anatomy , genetics , endocrinology , alternative medicine
In 2007 and 2008, we published two articles reporting a tamoxifen (TM)-inducible, chondrocyte-specific gene-targeting mouse model in which the expression of CreER(T2) is driven by the type II collagen promoter (Col2CreER(T2)). The fusion protein is specifically expressed and translocated into the nucleus upon TM administration, which in turn triggers gene recombination. Since then, this animal model has become a powerful tool to study the molecular mechanism of skeletal development and degenerative cartilage diseases, including knee joint osteoarthritis (OA), temporomandibular joint (TMJ) OA, and intervertebral disc (IVD) degeneration. In this review article, we summarise the application of Col2CreER(T2) mice and discuss the potential usage of this animal model in a broad spectrum of cartilage development and molecular pathology studies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom